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Abbreviation used
aN1: Active intracellular NOTCH1
DC: Dendritic cell
FITC: Fluorescein isothiocyanate
FLT3L: FMS-like tyrosine kinase 3 ligand
GFP: Green fluorescent protein
IDEC: Inflammatory dendritic epidermal cell
IRES: Internal ribosomal entry site
KLF4: Kruppel-like factor 4
LC: Langerhans cell
moDC: Monocyte-derived dendritic cell
moLC: Peripheral blood CD141 monocyte-derived Langerhans
cell
p-LC: CD341 progenitor cell–derived Langerhans cell
p-moDC: CD341 progenitor cell–derived monocyte-derived dendritic
cell
PPAR: Peroxisome proliferator-activated receptor
RUNX3: Runt-related transcription factor 3
SCF: Stem cell factor
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2 JURKIN ET ALBackground: Langerhans cell (LC) networks play key roles in
immunity and tolerance at body surfaces. LCs are established
prenatally and can be replenished from blood monocytes.
Unlike skin-resident dermal DCs (dDCs)/interstitial-type DCs
and inflammatory dendritic epidermal cells appearing in
dermatitis/eczema lesions, LCs lack key monocyte-affiliated
markers. Inversely, LCs express various epithelial genes critical
for their long-term peripheral tissue residency.
Objective: Dendritic cells (DCs) are functionally involved in
inflammatory diseases; however, the mechanisms remained
poorly understood.
Methods: In vitro differentiation models of human DCs, gene
profiling, gene transduction, and immunohistology were used to
identify molecules involved in DC subset specification.
Results: Here we identified the monocyte/macrophage lineage
identity transcription factor Kruppel-like factor 4 (KLF4) to be
inhibited during LC differentiation from human blood
monocytes. Conversely, KLF4 is maintained or induced during
dermal DC and monocyte-derived dendritic cell/inflammatory
dendritic epidermal cell differentiation. We showed that in
monocytic cells KLF4 has to be repressed to allow their
differentiation into LCs. Moreover, respective KLF4 levels in
DC subsets positively correlate with proinflammatory
characteristics. We identified epithelial Notch signaling to
repress KLF4 in monocytes undergoing LC commitment. Loss
of KLF4 in monocytes transcriptionally derepresses Runt-
related transcription factor 3 in response to TGF-b1, thereby
allowing LC differentiation marked by a low cytokine
expression profile.
Conclusion: Monocyte differentiation into LCs depends on
activation of Notch signaling and the concomitant loss of KLF4.
(J Allergy Clin Immunol 2016;nnn:nnn-nnn.)
Key words: Kruppel-like factor 4, Runt-related transcription factor
3, TGF-b1 signaling, Notch, lineage decision, monocyte
differentiation
Langerhans cells (LCs) are abundantly occurring dendritic
cells (DCs) in environment-exposed stratified epithelia.1 They
represent a well-defined DC subset marked by unique immuno-
phenotypic ultrastructural and functional characteristics.2 Among
various known human DC family members, LCs are identified as
CD1ahiCD2071 cells that express several epithelial molecules
(eg, E-cadherin, tumor-associated calcium signal transducer 2
[TACSTD2]/TROP2,3 epithelial cell adhesion molecule
[EpCAM]/TROP1,4 and claudin-15), allowing them to undergo
long-lasting adhesion to keratinocytes. LCs efficiently stimulate
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absence of microbial or danger signals, LCs continuously migrate
to T-cell areas of skin-draining lymph nodes.1
LCs lack expression of monocyte/macrophage lineage-affiliated
markers, including CD11b, CD36, lysozyme, CD209/DC-specific
intercellular adhesion molecule–grabbing nonintegrin, and c-fms/
monocyte colony-stimulating factor,7 as well as the early myeloid
lineage marker myeloperoxidase.8 However, LC development is
dependent on macrophage colony-stimulating factor receptor
(CD115, c-fms), and blood monocytes can differentiate into
LCs.9-12
Human monocytes can also differentiate into monocyte-
derived dendritic cells (moDCs; induced by GM-CSF and
IL-4), resembling inflammatory DCs in vivo (eg, inflammatory
dendritic epidermal cells [IDECs]), or into macrophages. Unlike
what is observed for LCs, monocyte lineage markers are
maintained in these (sub)lineages.13 Moreover, moDCs possess
a much higher capacity to synthesize proinflammatory
cytokines.14,15 The transcriptional mechanism underlying
monocyte/macrophage/moDC versus peripheral blood CD141
monocyte-derived Langerhans cell (moLC) differentiation
remains elusive.
LC differentiation from human hematopoietic progenitor cells
is marked by upregulation of transcription factors.16-18 LCs
express high levels of PU.1, and ectopic PU.1 promotes LC
differentiation from myeloid progenitors.19 PU.1 transactivates
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JURKIN ET AL 3for LC development.20 RUNX3 induction by PU.1 is context
dependent because ectopic PU.1 in myeloid progenitors
stimulates monocyte/macrophage and LC differentiation,
depending on the presence or absence of cosignals.19 Therefore
the critical molecular determinants of LC commitment are still
undefined.METHODS
In vitro culture of CD341 cord blood cells
For CD341 progenitor cell–derived Langerhans cell (p-LC), CD341
progenitor cell–derived monocyte-derived dendritic cell (p-moDC), or
monocyte generation, a previously described 2-step culture model21,22 was
used with slight modifications. In brief, sorted CD341 cells were cultured in
CellGro DC (CellGenix, Freiburg, Germany) medium supplemented
with 10% FCS, 100 ng/mL GM-CSF, 20 ng/mL stem cell factor (SCF),
50 ng/mL FMS-like tyrosine kinase 3 ligand (FLT3L), and 2.5 ng/mL
TNF-a for 5 days before subculturing in RPMI (Sigma, St Louis,
Mo; 110% FCS) under lineage-specific cytokine conditions (100 ng/mL
monocyte colony-stimulating factor, 50 ng/mL FLT3L, 20 ng/mL SCF,
2.5 ng/mL TNF-a, and 2 ng/mL IL-6 for monocytes; 100 ng/mL GM-CSF,
2.5 ng/mL TNF-a, and 25 ng/mL IL-4 for p-moDCs; and 100 ng/mL
GM-CSF, 2.5 ng/mL TNF-a, and 1 ng/mL TGF-b1 for p-LCs). Clusters
were purified by means of 1 g of sedimentation, as previously described.23
For generating moDCs, purified CD141 blood monocytes were cultured
in RPMI medium supplemented with GM-CSF (100 ng/mL) and IL-4
(25 ng/mL) in the presence of 10% FCS for 7 days. For generating moLCs,
purified CD141 blood monocytes were cultured in 24-well plates
coated with Delta-1, as previously described,24 in the presence of
GM-CSF (100 ng/mL) and TGF-b1 (10 ng/mL) for 5 to 6 days (RPMI
medium and 10% FCS). All cultures were supplemented with GlutaMAX
(2.5 mmol/L; Gibco/Invitrogen, Grand Island, NY) and penicillin/
streptomycin (125 U/mL each; PAA, Pasching, Austria).RNA isolation and quantitative PCR
Cellswere harvested and total RNAwas isolatedwith the RNeasyMicroKit
(Qiagen, Hilden, Germany). Purified RNA was reverse transcribed with
oligo-dT-primers (Eurofins MWG GmbH, Ebersberg, Germany) and reverse
transcriptase (M-MLV-RT-H-; Fermentas, Waltham, Mass), according to the
manufacturer’s instructions. Quantitative PCR was performed in a Roche
LightCycler (Roche,Mannheim,Germany)with PlatinumSYBRGreen qPCR
SuperMix-UDG (Invitrogen, Carlsbad, Calif). Values were normalized to
hypoxanthine phosphoribosyltransferase (HPRT). Primers are listed in Table
E1 in this article’s Online Repository at www.jacionline.org.Flow cytometry
Flow cytometric staining and analyses were performed, as previously
described.25 Flow cytometric analysis was performed with an LSRII
instrument (BD Biosciences, San Jose, Calif) and FlowJo software (TreeStar,
Ashland, Ore). For FACS sorting, the BD FACSAria flow cytometer (BD
Biosciences) was used. Used antibodies are listed in Table E2 in this article’s
Online Repository at www.jacionline.org.Western blot analysis
ForWestern blot analysis, lysates of 1 to 23 106 cells per lanewere loaded,
and resolved proteins were transferred to a polyvinylidene difluoride
membrane (Immobilon-P; Millipore, Temecula, Calif). Membranes were
probed with antibodies against Kruppel-like factor 4 (KLF4; Santa Cruz
Biotechnology, Dallas, Tex), RUNX3 (a kind gift of S. Sakaguchi, Vienna,
Austria), or b-actin (Sigma-Aldrich, St Louis, Mo), followed by horseradish
peroxidase–conjugated goat anti-rabbit IgG antibodies (Pierce Biotechnology,
Rockford, Ill). Antibody binding was visualized with the chemiluminescent
substrates SuperSignal West Pico or West Dura (Pierce Biotechnology).Cytokine measurement
Cells were seeded (1 3 104 to 2 3 104/200 mL) in 96-well plates, and
supernatants were collected 48 hours later, as previously described.26
Cytokine (IL-6, IL-10, IL-8, TNF-a, and IL-12p40) levels were quantified
with the Luminex system (Luminex, Austin, Tex).Statistical analysis
Statistical analysis was performed with the paired, 2-tailed Student t test or
ANOVA. P values of less than .05 were considered significant.
Detailed descriptions of cytokines and reagents, sources for cells and skin
tissue, isolation of immune cells for microarray studies, mRNA microarray
and data analysis, retroviral vectors, confocal microscopy, and the chromatin
immunoprecipitation assay are presented in the Methods section in this
article’s Online Repository at www.jacionline.org.RESULTS
KLF4 is inversely regulated during LC versus
monocyte differentiation of myeloid progenitor
cells
TGF-b1 induces the generation of CD1a1CD2071 p-LCs at
the expense of monocytes/macrophages when added to
serum-free, cytokine-supplemented cultures (GM-CSF, SCF,
FLT3L, and TNF-a) of CD341 hematopoietic progenitor cells.8
We screened for TGF-b1–regulated transcription factors during
p-LC commitment. CD341CD192 cells were subfractionated
into CD45RAlow/2, CD45RAint, and CD45RAhi subsets (Fig 1,
A, initial myelopoiesis).27-30 These subsets were prestimulated
with GM-CSF, SCF, FLT3L, and TNF-a for 48 hours to bias their
differentiation to monocytes. Thereafter, TGF-b1 was added to
induce p-LC differentiation; parallel cultures were maintained
without TGF-b1 addition to further promote monocyte
development (Fig 1, A).8 Only CD45RAhi cells, representing
the most differentiated myeloid progenitor subset, exhibited
capacity to differentiate into CD1a1CD2071 p-LCs or
CD141CD11b1 monocytes (Fig 1, A). To enrich for functional
LC precursors, we used these CD45RAhiCD341 cells for micro-
array profiling (Fig 1, B). Conversely, all the subsequently
described cell-culture experiments (see below) were done with
total CD341 cells.
From mRNA analysis (Fig 1, B), we identified several ‘‘proof-
of-concept’’ molecules being induced in TGF-b1–supplemented
cultures, such as claudin-1, E-cadherin, CD207, or CCR6 (see
Table E3 in this article’s Online Repository at www.jacionline.
org); vice versa, monocyte/moDC-associated markers (CD36,
CLEC10, MRC1, or FXIIIA)were repressed under LC
conditions (see Table E4 in this article’s Online Repository at
www.jacionline.org). Three groups of differentially regulated
transcription factors were identified: (1) factors rapidly induced
in TGF-b1–containing cultures, including DEC1, VDR,
RUNX3, RXRa, and RFX2; (2) factors induced late at 24 hours
in the presence of TGF-b1 (DEC2 and peroxisome proliferator-
activated receptor [PPAR] g) or slightly induced in absence of
TGF-b1 (BLIMP-1); and (3) factors rapidly repressed in
TGF-b1–containing cultures, including ETS-2 and KLF4.
Among these, KLF4 was the only factor significantly inversely
regulated under p-LC versus monocyte differentiation conditions
(ie, repressed during p-LC [1TGF-b1] but induced during
monocyte [2TGF-b1] differentiation; Fig 1, C). KLF4 induces
monocyte differentiation,31,32 and therefore it might be
involved in regulating alternate lineage fate options of shared
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FIG 1. Identification of transcription factors regulated during LC commitment. A, Sorted CD341CD45RAlow,
CD341CD45RAint, and CD341CD45RAhigh progenitor subsets cultured for 7 days undermonocyte-promoting
(–TGF-b1) or LC-promoting (1TGF-b1) conditions. B, Schematic representation of microarray set-up.
C, Quantitative PCR validation of selected transcription factors (n 5 4-8, 6 SEM). *P < .05, **P < .01, and
***P < .001, t test.
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4 JURKIN ET ALmonocyte/LC progenitor cells. KLF4 is a member of the family of
Kruppel-like factors carrying conserved DNA binding zinc
fingers but lacking homology outside DNA-binding regions.33
Apart from KLF10 (TIEG1), an immediate early TGF-b1–
inducible factor in various cell types,34 and KLF6, none of the
other KLF family members underwent significant regulation in
our screen (see Table E5 in this article’s Online Repository at
www.jacionline.org).KLF4 protein is inversely regulated during moLC or
moDC generation from CD141 monocytes
Murine inflammatory monocytes are KLF41 and require KLF4
for differentiation.32 These cells can give rise to LCs under in-
flammatory conditions.9 Congruent with previous observations,12
the Notch ligand Delta-1 cooperates with TGF-b1 to induce LCs
from CD141 blood monocytes (moLCs; CD1a1CD2071 cells).
KLF4 was repressed to virtually undetectable levels during
moLC differentiation (Fig 2, A, right panel). Conversely, addition
of TGF-b1 alone (ie, without Delta-1) to GM-CSF–supplemented
cultures resulted in the generation of macrophages
(CD141CD11b1CD1a2) exhibiting marked upregulation of
KLF4 protein (Fig 2, A). In fact, KLF4 expression levels were
increased in GM-CSF plus TGF-b1–supplemented cultures
compared with those in cells stimulated with GM-CSF only.
Stimulation of monocytes with GM-CSF only in the presence ofDelta-1 caused repression of KLF4 (Fig 2, A). KLF4 was also
abundantly expressed in CD1a1 moDCs generated in the
presence of GM-CSF plus IL-4 (Fig 2, A).
IFN-g was previously shown to enhance KLF4 expression in
monocytes.35 Consequently, we analyzed whether KLF4 is
induced in CD341-derived p-LCs or p-moDCs in response to
IFN-g stimulation for 2 days. Although IFN-g did not induce
KLF4 in p-LCs, p-moDCs showed marked upregulation of
KLF4 on treatment (Fig 2, B).
Time kinetic analyses of monocyte/LC precursors generated
fromCD341 progenitors22 revealedweakKLF4 expression at day
0 (Fig 2, C). These precursors can be induced to differentiate into
p-LCs, p-moDCs (Fig 2, C and D), or macrophages. KLF4 was
induced during p-moDC and macrophage but not p-LC differenti-
ation (Fig 2,C). Expectedly, p-moDCs and p-LCs showed inverse
expression of CD207, CD209, and CD11b (Fig 2, D). Purified
CD341 cell–derived p-LCs clearly lacked detectable KLF4 (Fig
2, E). Consistently, omission of TGF-b1 from the LC-inducing
cytokine mix was accompanied by KLF4 induction (Fig 2, F).LCs and their precursors lack detectable KLF4,
whereas dermal DCs are KLF41
LCs in adult human skin (HLA-DR1CD2071 epidermal cells)
lacked detectable KLF4 (Fig 3, A, right panel, arrow), whereas all
keratinocyte layers exhibited a nuclear KLF4 expression pattern.
FIG 2. KLF4 is downregulated during LC differentiation. A, KLF4 expression of CD141 blood monocytes
stimulated with indicated cytokines. B, KLF4 expression of FACS-purified p-LCs or p-moDCs (6 IFN-g).
C, FACS and KLF4 expression analysis of day 7 p-moDCs, p-LCs, or progenitor-derived monocytes
(p-monocytes). D and E, Lineage marker profile (Fig 2, D) and KLF4 expression (Fig 2, E) of CD1a1 cells of
day 7 p-moDC or p-LC cultures. F, FACS and Western blot analysis of day 5 progenitors cultured with or
without TGF-b1 for 7 days (n 5 3).
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JURKIN ET AL 5Moreover, KLF4 was readily detectable in HLA-DR1 dermal
cells (Fig 3, A, right panel, arrowhead). Because LCs develop
prenatally from epidermal resident precursors, we also analyzed
prenatal human skin. HLA-DR1 cells in embryonic epidermis
at 9 weeks of estimated gestational age (EGA)36 lack KLF4
(Fig 3, A, left panel, enlarged right panel), whereas
HLA-DR1KLF41 dermal cells could be identified. KLF4 could
be detected at varying levels in most adult CD1a1 and CD141
dermal DCs, whereas epidermal CD1a1 cells lacked KLF4
(Fig 3, B and C). Grading was performed according to reference
levels of KLF4 in keratinocyte layers (outer layers, high;
suprabasal, intermediate; and basal, low). Gene profiling of
FACS-sorted cell subsets confirmed that both dDC subsets,
monocytes, and keratinocytes express KLF4 mRNA at high
levels, whereas it is virtually undetectable in LCs (Fig 3, D).Notch signaling is activated in LCs
Notch activation in response to Delta-1 represses KLF4, as well
as the monocyte lineage markers CD14 and CD11b, in bloodmonocytes. Moreover, Delta-1 is required for TGF-b1–induced
moLC differentiation (Fig 2, A). CD1a1 epidermal LCs stain
strongly positive for an antibody specific for active intracellular
NOTCH1 (aN1)37-39; conversely, they lack KLF4 (Fig 4, A, upper
panel). Consistently, CD2071 cells generated from monocytes or
CD341 cells are aN11 but KLF42 (Fig 4, A, lower panel).
Inversely, moDCs lack aN1 expression but are strongly KLF41.
Positive aN1 reactivity of LCs was confirmed by using a
chromogen-based immunohistochemistry method (see Fig E1 in
this article’s Online Repository at www.jacionline.org).
The above-described microarray screen (Fig 1, B) revealed
induction of Notch signaling pathway members by TGF-b1
within 6 hours. TheNotch signature geneHES1was induced along
withNOTCH1 receptor and JAG2 ligand, aswell as components of
the g-secretase complex (PSEN1 and PSEN2; Fig 4, B, and see
Table E6 in this article’s Online Repository at www.jacionline.
org). Consistently, NOTCH1 was induced in response to TGF-
b1 signaling in hematopoietic progenitors within 24 to 72 hours
(Fig 4,C, upper panel). Moreover, a portion of day 5 p-LC precur-
sors expressed JAG2, which was further upregulated in day 7
FIG 3. LCs and prenatal LC precursors do not express KLF4. A, LCs and prenatal HLA-DR1 LCs are indicated
by arrows, and dermal HLA-DR1 cells are indicated by arrowheads (n 5 4 per developmental stage).
B, Staining of dermal CD141 or CD1a1 DCs of adult human skin. C, Grading of KLF4 expression of dDCs
(n 5 6). D, KLF4 mRNA levels of LCs, monocytes (Mo), CD1a1 dDCs, or CD141 dDCs and keratinocytes
(KC) isolated from healthy adult human skin (n 5 3).
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FIG 4. KLF4 is repressed by Notch signaling. A, Sections of healthy human skin (top) and cytospun in vitro–
generated p-LCs, moLCs, and moDCs (bottom). B, TGF-b1–dependent upregulation/downregulation of
Notch target genes after 6 and 24 hours (n 5 3). C, NOTCH1 and JAG2 surface expression of CD341
progenitors and p-LC generation cultures (n 5 4). D, FACS analysis of intracellular active NOTCH1 (aN1)
of day 5 moLCs and moDCs and day 7 p-LCs (n 5 4).
J ALLERGY CLIN IMMUNOL
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JURKIN ET AL 7generated CD1a1CD2071 p-LCs (Fig 4, C, lower panel). Notch
signaling occurs through a cell contact–dependent mecha-
nism.40 Consistently, p-LC generation cultures exhibited typical
cell clustering involving E-cadherin adhesion41,42 and aN1 pos-
itivity (Fig 4, D). These characteristics were not observed in
GM-CSF/IL-4–dependent p-moDC differentiation cultures, irre-
spective of the presence or absence of exogenous TGF-b1.Ectopic KLF4 represses LC differentiation from
monocyte/LC precursors
CD341 progenitors were transduced with KLF4–internal ribo-
somal entry site (IRES)–green fluorescent protein (GFP) or empty
control vector and subsequently induced to differentiate for 5 days
into monocyte/LC precursors (schematically shown in Fig 2,
C).22 Ectopic KLF4 reduced percentages of CD1a1 cells in favor
of CD141CD1a2 cells (Fig 5, A), whereas a KLF4 mutant
(KLF4DZNF-IRES-GFP), lacking DNA-binding activity but
still retaining the transactivation/transrepression domain,35,43
showed the opposite effect (Fig 5, A, right panel). Consistently,
KLF4 overexpression strongly inhibited whereas KLF4DZNF
promoted p-LC generation from monocyte/LC precursors
(Fig 5, B).
We next generated day 5monocyte/LCprecursors (according to
Fig 2, C, FACS plot day 0) and analyzed consequences of KLF4overexpression on p-LC differentiation by using an inducible
retroviral system (Fig 5, C).26 Expanded progenitor cells were
transducedwith 2 retroviral vectors (inducible ‘‘tet-on’’system26),
followed by the generation of DC precursors in primary cultures.
Thereafter, cells were subcultured under secondary LCgeneration
conditions in the presence of doxycycline to induce KLF4-IRES-
GFP or empty control–GFP (Fig 5, C). FACS analysis of GFP1
cells was then performed at day 7 in LC generation cultures.
The induction ofKLF4 at the stage ofDCprecursorswas sufficient
to inhibit p-LC generation (Fig 5, D). Conversely, ectopic KLF4
expression in CD341 cells did not inhibit but rather promoted
generation of p-moDCs (CD2072CD2091CD11b1CD1a1 cells;
Fig 5, E, and see Fig E2, A, in this article’s Online Repository at
www.jacionline.org).
Apart from phenotypic characteristics, LCs and moDCs also
differ in functional properties. p-LCs expressed substantially
lower levels of proinflammatory cytokines than p-moDCs (Fig 5,
F and G), confirming previous observations.14,44 KLF4-
transduced p-moDCs showed slightly higher mean production
levels of proinflammatory cytokines relative to controls (Fig 5,
F). However, these data did not reach statistical significance in
paired t test statistics. Consistent with the observed repression
of KLF4 during LC differentiation, KLF4DZNF transduced
p-LCs equaled control transduced cells in low levels of cytokine
production.
FIG 5. Ectopic KLF4 interferes with LC differentiation. A, FACS of GFP1 day 5 progenitors (n 5 6). *P < .05
and **P < .01, t test. B, Day 5 progenitors subcultured with TGF-b1 (n 5 6). *P < .05 and ***P < .001, t test.
C, Schematic representation of experimental set-up for KLF4 induction. D, CD1a/CD207 expression of day 7
GFP1 cells cultured according to Fig 5, C (n 5 3). *P < .05, t test. E, FACS of day 5 progenitors subcultured
under p-moDC conditions (n5 6). F andG, Cytokine secretion of day 7 GFP1CD1a1CD2071 p-LCs (Fig 5, F) or
GFP1CD1a1CD11b1 p-moDCs (Fig 5, G; 6 1 mg of Pam3CSK4; n 5 3).
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8 JURKIN ET ALRUNX3 and KLF4 are inversely regulated during LC
and moDC differentiation
RUNX32/2micewere shown to lack LCs.18 RUNX3mRNA is
strongly induced concomitant with LC differentiation (Fig 1, C).
RUNX3 protein was induced during p-LC (1TGF-b1) but
remained low/undetectable under monocyte (2TGF-b1)
differentiation conditions, whereas KLF4 showed an inverse
expression pattern (Fig 6, A). Furthermore, RUNX3 was
expressed by moLCs but by neither moDCs nor macrophages
generated from peripheral blood monocytes (Fig 6, B, and see
also Fig 2, A).Ectopic RUNX3 promotes LC but inhibits moDC
differentiation
Ectopic expression of RUNX3 in CD341 cells promoted the
generation of day 5 p-LC precursors (CD1a1 cells) at the expense
of monocyte precursors (CD141CD1a2 cells; Fig 6, C). Accord-
ingly, RUNX3 promoted the generation of CD1a1CD2071 p-LCs
in secondary cultures in the absence or presence of TGF-b1
(Fig 6, D). Furthermore, RUNX3 reduced percentages of
CD11b1CD2091CD1a1 p-moDCs generated in the presence of
GM-CSF plus IL-4 in favor of CD11b2CD2092CD1a1CD2071
p-LCs (Fig 6, E, and see Fig E2, B).Inhibition of TGF-b1–mediated RUNX3 induction by
ectopic KLF4 is counteracted by RUNX3
overexpression
CD341 cells were transduced with KLF4-IRES-GFP or empty
control vector and induced to differentiate into p-LCs or
monocytes (schematically shown in Fig 2, C). TGF-b1–mediated
RUNX3 induction was substantially impaired in KLF4-
transduced cells (Fig 7, A and B). In comparison, other
TGF-b1–induced genes from the screen, such as TIEG1 and
SMAD7, were not repressed by KLF4 (Fig 7, C). Consistently,
KLF4 binds to the RUNX3 promoter in KLF41 p-moDCs
(Fig 7, D), and ectopic RUNX3 overcame the inhibitory effect
of KLF4 partially on the generation of CD1a1CD142 and total
CD1a1 cells (Fig 7, E). It could re-establish the generation of
CD1a1CD2071 p-LCs from KLF4-transduced progenitor cells
(Fig 7, F).DISCUSSION
Despite DCs having been recognized as involved in inflamma-
tory skin diseases, the mechanisms of human DC differentiation
in steady state versus inflammation remained poorly defined.
Herewe demonstrated that Notch signaling–dependent repression
of KLF4 is critical for LC commitment of monocytes. Loss of
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derepression of RUNX3. Moreover, we identified KLF4 as a
key switch factor regulating differentiation of monocytes into
LCs versus moDCs/dDCs. Our study highlights the role of signals
within the epidermal/epithelial microenvironment for instructing
LC commitment of monocytes (see graphic abstract).
KLF4 is a monocyte lineage identity factor known to promote
monocyte commitment of myeloid progenitors.31 As such,
KLF4 induces a set of monocyte lineage-associated molecules.
Among these, CD11b is well known as a critical marker for
classifying DC subsets. CD11b is strongly expressed by
in vitro–generated moDCs, and high levels of CD11b are a
phenotypic hallmark of IDECs, the latter representing putative
monocyte-derived dendritic cells in atopic dermatitis/eczemalesions.45 Additionally, CD11b is expressed by the 2 major
subsets of dDCs (CD1a1 and CD141). We detected KLF4 in
dDCs and in ex vivo–generated moDCs, which were previously
shown to be phenotypically similar to IDECs.45 The previous
demonstration that ectopic wild-type KLF4 induces CD11b in hu-
man myeloid progenitor cells31 is therefore supportive to the here
observed positive correlation between KLF4 and CD11b among
skin DC subsets. Consistently, stage-dependent loss of LC but
not moDC differentiation potential during successive steps of
monocyte/macrophage differentiation marked by CD11b was
previously noted in cultures of CD341 precursors.46
Our observation that KLF4 promotes CD11b1 moDC/dDC
differentiation is reminiscent of previously observed functions
of RelB.25 RelB promotes CD11b1 moDC/dDC differentiation
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of monocytic CD11b1 intermediates. Interestingly, CD11b1
classical DCs dependent on KLF4 or RelB have also been
described in the murine system.47,48
Here we describe epithelial Notch activation–dependent KLF4
repression, whichmight allow LC differentiation frommonocyte-
committed cells under inflammatory conditions. Human CD141
dDCs express KLF4; these cells can reconstitute LCs in vivo.49
Similarly, murine Gr1hi monocytes are dependent on KLF432
and can reconstitute LCs in vivo.9 We also detected KLF4 in fetal
dermal HLA-DR1 cells, opening the possibility that such cells
might give rise to LCs in prenatal epidermis. Reminiscent of
similar observations in endothelial cells,50 here we demonstrated
that TGF-b1 induces Notch signaling pathway members in
monocytopoietic cells undergoing LC commitment.
Interestingly, human CD1c1 blood DCs differentiate into LCs
without exogenous Notch ligand (ie, GM-CSF plus eitherTGF-b1 or BMP7).51 Whether Notch signaling is activated
during CD1c1 blood DC–derived LC differentiation remains to
be analyzed.
In support of our findings, cleaved NOTCH1 was previously
shown to bind to a specific site within the KLF4 promoter,52 and
antagonism between KLF4 and Notch signaling has been
documented in nonhematopoietic cells.52 Moreover, it was
previously described that KLF4 can inhibit the negative effect
of TGF-b1 on proinflammatory cytokine expression.53 Because
it has been demonstrated that LCs can cause induction of
regulatory T cells,54,55 lack of KLF4 by LCs might indicate their
involvement in tolerogenic functions.
Our study confirms previous observations claiming that the
Notch ligand Delta-1 facilitates DC differentiation from
monocytes by inhibiting default macrophage differentiation.56
Delta-1 alone repressed KLF4 in monocytes along with the
induction of certain DC characteristics, such as CD1a expression.
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low CD14 levels. It is interesting to speculate that these cells
represent intermediate stages of LC differentiation from
monocytes. Downregulation of KLF4 through Delta-1 in these
cells might allow TGF-b1–induced terminal differentiation of
LCs within the epidermis. KLF4 downregulation is not generally
required for skin DC development because, unlike LCs, dDCs and
moDCs express KLF4.
RUNX3-deficient mice lack LCs, and similarly, LCs are
missing in mice in which RUNX3 has been conditionally deleted
in CD11c1 cells.20 Here presented data support the concept that
RUNX3 is a critical positive regulator of LC differentiation. In
addition to RUNX3, LC development in vivo requires ID2.57
Unlike observed for RUNX3, ectopic ID2 did not promote LC
differentiation.19 However, ID2 mRNA levels are suppressed by
KLF4 overexpression in LCs (see Fig E2, C). Our screen
identified additional factors induced during LC differentiation,
which might also be involved in a transcription factor network
regulating LC differentiation (eg, VDR,16 as well as DEC1,
DEC2, BLIMP-1, and PPARg).
We thank G. Zlabinger and M. Merio for cytokine measurements, M. Jaritz
for heat map illustration with Spotfire, W. Ellmeier and J. St€ockl for critically
reading the manuscript, and T. Bauer for designing the graphic abstract.
Key messages
d KLF4 positively regulates differentiation of CD11b1 in-
flammatory DCs.
d KLF4 represses RUNX3 and thereby inhibits tolerogenic
LC commitment.
d Notch signaling inhibits KLF4 during monocyte to LC
lineage conversion.REFERENCES
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METHODS
Cytokines and reagents
SCF, thrombopoietin, TNF-a, GM-CSF, FLT3L, IL-6, IFN-g, IL-4,
and macrophage colony-stimulating factor were purchased from
PeproTech (Rocky Hill, NJ). TGF-b1 was from R&D Systems
(Minneapolis, Minn). Pam3CSK4 was purchased from InvivoGen (San Diego,
Calif). The recombinant extracellular domain of Notch ligand Delta-1
(Delta-1ext–IgG) was kindly provided by I. Bernstein (Seattle, Wash). Coating
of Delta-1ext–IgG was performed, as previously described.E1
Sources of cells and skin tissue
CD341 cells were obtained from cord blood samples from healthy donors.
Blood samples were collected during healthy full-term deliveries and
prepared, as previously described.E2 CD341 hematopoietic progenitors
were isolated by means of immunomagnetic positive selection (EasySep;
STEMCELL Technologies, Vancouver, British Columbia, Canada). For the
microarray screen, CD341CD192 cells were subsorted into CD45RAlow/2,
CD45RAint, and CD45RAhi subsets by means of FACS and analyzed sepa-
rately. For all differentiation experiments, the total CD341 cell fraction was
used. For in vitro differentiation cultures, CD141 monocytes were isolated
from PBMCs by means of positive selection with magnetic beads (Miltenyi
Biotec, Bergisch Gladbach, Germany). For microarray experiments, CD141
monocytes were FACS sorted, as described below. Skin was obtained from
healthy adults undergoing elective surgery (breast reduction or
abdominoplasty).E3 For prenatal skin staining, specimens of human
embryonic trunk skin (range, 9-10 weeks of EGA) were studied after legal
termination of pregnancy. Approval was obtained from the Vienna Medical
University Institutional Review Board. Informed consent was provided in
accordance with the Declaration of Helsinki.
Isolation of immune cells for microarray studies
Epidermal LCs and keratinocytes, as well as dermal cell populations, were
isolated from healthy human skin. Briefly, after separation of dermal and
epidermal sheets by means of incubation with Dispase I (3 U/mL; Roche),
single cells were released from epidermal sheets by using 0.25%
trypsin/EDTA (Invitrogen) for 30 minutes at 378C. CD11b2CD1a1 LCs
(n5 4) and CD11b2CD1a2 keratinocytes (n5 1) were sorted from epidermal
cell suspensions on a FACSAria (BD Biosciences). For preparation of dermal
cell suspensions, dermal sheets were dissociated with 0.5 U/mL collagenase
IV (Worthington Biochemical, Lakewood NJ) for 90 minutes at 378C. Dermal
cells were sorted into CD1a1 dDCs (CD1a1CD11b1CD142, n 5 3), and
CD141 dDCs (CD141CD11b1CD1a2, n 5 3). Monocytes were isolated
from buffy coats obtained from the Austrian Red Cross. Briefly, after Ficoll
Hypaque (Pharmacia, Uppsala, Sweden) density gradient centrifugation,
PBMCs were depleted of Lin1 cells (CD3, CD16, CD34, CD56, and glyco-
phorin A), and CD141CD11b1CD192CD1c2 monocytes were sorted by us-
ing a FACSAria. The purity of all cell populations used was at least 98%.
Sorted cells were pelleted and lysed in TRI Reagent (Sigma-Aldrich), and
RNAwas isolated, according to the manufacturer’s recommendations.
mRNA microarray and data analysis
Cells were collected at indicated time points (0, 6, and 24 hours after
addition of TGF-b1). Total RNA from 6 independent donors was isolated by
using the RNeasyMicro Kit (Qiagen). RNA samples were then combined into
2 separate pools (each containing RNA from 3 independent donors), labeled,
and hybridized onto U133 Plus 2.0 Affymetrix GeneChips (Affymetrix, Santa
Clara, Calif). Top hundred nanograms of total RNA per sample was processed
by using Ambion’s MessageAmp II Biotin Enhanced Labeling Kit (Ambion,
Thermo Fisher, Waltham, Mass). Gene chips were stained, washed, and
scanned according to Affymetrix standard procedures. The probe level data
(CEL files) were processed for local normalization, and expression values
were generated by using the robust multiarray average algorithm of the ‘‘affy
package’’ in the R software environment (http://www.R-project.org). The mi-
croarray data have been deposited in the Gene Expression Omnibus database
(http://www.ncbi.nlm.nih.gov/goe/) and can be accessed as GSE31318. For
mRNA profiling of immune cells isolated from skin, total RNAwas subjected
to 2 rounds of linear amplification, as previously described.E4,E5
Biotin-labeled ribonucleotides were incorporated by using the ENZO
Bio-Array High-Yield RNATranscript Labeling Kit (Affymetrix) during the
second round of in vitro transcription. Fragmented cDNA (10 mg) was
hybridized to Human Genome U133 Plus 2.0 Array (Affymetrix). Microarray
data were normalized by using the robust multiarray analysis, as implemented
in Bioconductor.E6,E7
All analyses were performed with log2-transformed data. The Ingenuity
Pathway Analysis (http://www.ingenuity.com) tool was used to assign
microarray data sets to common biological pathways and to define gene sets
attributed to Notch signaling. Analysis was performed for genes showing
regulated expression under TGF-b1–supplemented versus nonsupplemented
culture conditions after 6 and 24 hours (cutoff: fold change, 1.3). Differential
expression of Notch was determined by using a heat map with Spotfire
software (http://www.spotfire.tibco.com/).
Transfection of packaging cell lines and gene
transduction
Gene transductionwas performed, as previously described.E8,E9 Briefly, the
packaging cell line Phoenix-Gag-Pol (Ph-GP) was used for generating GALV
envelope–containing retroviral particles. Target cells were plated on
RetroNectin (Takara Bio, Shiga, Japan)–coated non–tissue culture plates
coated with virus (3-5 hours) in specific growth medium. Infections were
repeated 2 to 3 times at intervals of 12 to 24 hours. CD341 cells were infected
in expansion mix (SCF, FLT3L, and thrombopoietin; each 50 ng/mL). The
retroviral tetracycline-inducible system (tet-on system) was described
previously.E8 Briefly, the first vector encoded the Tet activator pTA-mCD8a.
The second vector encoded human KLF4-IRES-GFP under the control of a
Tet-responsive element. CD341 cells were first infected with TA-mCD8a,
followed by infection with the Tet-response vector. Expression of the KLF4
transgene was induced by addition of 1 mg/mL doxycycline. Fresh
doxycycline was added every 2 to 3 days of LC differentiation culture to
sustain KLF4 expression (GM-CSF, TNF-a, and TGF-b1; secondary
cultures).
Retroviral vectors
RV-GFP and RV-KLF4-GFP vectors were kindly provided by M. W.
Feinberg.E10 KLF4-coding DNAwas inserted into the BglII/XhoI sites of the
MSCV-IRES-GFP vector. Cutting RV-KLF4withBglII andXhoI and inserting
it into MSCV-IRES-NGFR vector generated MIN-KLF4. MIG-RUNX3 was
kindly provided by S. Sakaguchi (Vienna, Austria). HR-KLF4-IGFP was
generated by cutting RV-KLF4-GFP with BglII and XhoI and inserting it
into the BamHI/XhoI site of the pHR-IGFP vector (kindly provided by
F. Rossi, Vancouver, British Columbia, Canada).
Immunohistochemistry staining
Double-labeled immunohistochemical staining was performed on
paraffin-embedded sections or cytospin preparations by using the LabVision
MultiVision Polymer Detection System (anti-mouse AP, anti-rabbit
horseradish peroxidase), according to the commercial protocol (Thermo
Fisher Scientific). The following primary antibodies were used: monoclonal
mouse anti-CD1a (Novus Biologicals, Littleton, Colo), polyclonal rabbit
anti-activated Notch-1 (Abcam, Cambridge, Unite Kingdom), and polyclonal
rabbit anti-KLF4 (Sigma-Aldrich).
Confocal microscopy
Multicolor immunofluorescent staining procedures were performed on
frozen sections, as previously described.E11 Negative controls were obtained
in all staining experiments by substituting primary antibody with the
isotype-matched IgG. Slides were mounted in Permafluor (Thermo Fisher
Scientific) or VECTASHIELD (Vector Laboratories, Burlingame, Calif).
Immunofluorescently labeled sections were analyzed with a Zeiss LSM 520
confocal microscope (340/1.3 NA; Zeiss, Oberkochen, Germany), and
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images were captured with Zen 2008 Software (Zeiss). The following primary
antibodies were used: polyclonal rabbit anti-KLF4 (Sigma-Aldrich); mouse
anti-CD207 (Immunotec, Vaudreuil-Dorion, Quebec, Canada), fluorescein
isothiocyanate (FITC)–conjugated mouse anti-CD11b (Immunotec),
FITC-labeled mouse anti–HLA-DR (BD Biosciences), polyclonal rabbit
anti-activated Notch-1 (Abcam), monocloncal mouse anti-CD1a (Novus
Biologicals), polyclonal goat anti-CD14 (Novus Biologicals), and
FITC-labeled mouse anti-CD14 (BioLegend, San Diego, Calif). Alexa Fluor
488–conjugated anti–Laminin-5 (Millipore, Temecula, Calif) was used to
visualize the dermal-epidermal junction. Anti-FITC polyclonal goat IgG
(Invitrogen) and anti-rabbit polyclonal goat F(ab9)2 fragment (Jackson
ImmunoResearch, West Grove, Pa) or goat anti–rabbit Alexa Fluor 647
(Invitrogen), donkey anti-rabbit Rhodamine Red-X (Jackson Immuno-
Research), donkey anti-mouse Alexa Fluor 488 (Jackson ImmunoResearch),
and donkey anti-goat Alexa Fluor 647 (Jackson ImmunoResearch) antibodies
served as secondary reagents. All secondary antibodies have been
cross-absorbed to avoid cross-reactivity with IgG of other species.
Chromatin immunoprecipitation assay
CD141 peripheral blood monocytes were induced to differentiate with
GM-CSF (100 ng/mL) and IL-4 (25 ng/mL) into moDCs. KLF4 chromatin
immunoprecipitation was performed with the KLF4 ExactaChIP Kit (R&D
systems), according to the manufacturer’s protocol. Briefly, moDCs
(63 106) were treated for 15minutes at 378Cwith 1% (vol/vol) formaldehyde,
followed by addition of glycine (final concentration, 125 mmol/L). Cells were
pelleted, resuspended in lysis buffer, lysed on ice, and sonicated to obtain
chromatin fragments of 0.5 to 1 kb in length. Equal amounts (5 mg) of goat
anti-human KLF4 antibody or of normal goat IgG were used per reaction.
The following primers were used for detection of the RUNX3 promotor
region: 59-GCAGCCCCAGAACAAATC-39 and 59-GCTACGACCCGAGA
GAGG-39. The abundance of distinct DNA fragments was quantified by
means of semiquantitative PCR; PCR products were resolved by using 2%
agarose gel electrophoresis.
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FIG E1. Immunohistochemical analysis of healthy human skin and in vitro–generated LCs. A, Paraffin
sections of healthy human skin were stained for CD1a (red) and aN1 (blue). Bars 5 10 mm. B, p-LCs and
moLCs were sorted by using anti-CD207 mAb with magnetic beads. Cells were spun on slides, fixed,
permeabilized and stained for CD1a and aN1. Bars 5 10 mm.
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FIG E2. Analysis of the inhibitory role of KLF4 on LC-like cell differentiation. A and B, KLF4-IRES-GFP–,
RUNX3-IRES-GFP–, or control-transduced day 5 precursors were cultured under LC-promoting conditions
(1TGF-b1). GFP1CD1a1-gated cells were analyzed for expression of CD207, DC-specific intercellular
adhesion molecule–grabbing nonintegrin (DC-SIGN; CD209), CD11b, and CD14. C, KLF4-IRES-GFP– or
control-transduced cells were cultured under LC-promoting cytokine conditions (1TGF-b1). After 24 hours,
GFP1 cells were sorted, and quantitative PCR analysis for ID2 mRNA expression was performed.
Bar diagrams represent mean 6 SEM values of 3 independent experiments.
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TABLE E1. Primers used for quantitative PCR
Primer name Orientation Sequence
RFX2 Forward ATA GAT GTC TCC CAC TGC TTC
Reverse TCT CGA TGT AGT GGA ACT GGA G
TIEG Forward CCA GGA TGT GGC AAG ACA TAC
Reverse TTC ACA ACC TTT CCA GCT ACA G
BLIMP-1 Forward CGG CAA GAT CAA GTA CGA ATG
Reverse GAG CTG AGT AAA GCC CTT GTT G
ETS-2 Forward TTG TGG GTG ACA TTC TCT GG
Reverse ATG AGG AAC GGA GGT GAG G
DEC2 Forward CCT ACC GTC CCA CAG ATT G
Reverse CCT TGG TGT CGT CTC GTT TC
DEC1 Forward TGA CCG GAT TAA CGA GTG C
Reverse GAG CAG AAC ATC TCT TGA CCT G
KLF4 Forward GCC GCT CCA TTA CCA AGA G
Reverse GTG CCT TGA GAT GGG AAC TC
PPARd Forward TCA CAC AGT GGC TTC TGC TC
Reverse TCT ACA GGG TGG TTC CCA TC
RXRa Forward CGA CCC TGT CAC CAA CAT TTG C
Reverse GAG CAG CTC ATT CCA GCC TGC C
VDR Forward AGA TGA CCC TTC TGT GAC CC
Reverse AGC TTG TTC AGT CCC ACC TG
HPRT Forward GAC CAG TCA ACA GGG GAC AT
Reverse AAC ACT TCG TGG GGT CCT TTT C
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TABLE E2. Antibodies used for flow cytometry
Primary antibodies
Antigen Conjugate Distributor
CD34 FITC BD Biosciences
CD14 FITC BD Biosciences
HLA-DR FITC BD Biosciences
CD1a FITC BD Biosciences
CD1c FITC Miltenyi Biotec GmbH
CD11b FITC Immunotech
CD207 FITC Miltenyi Biotec GmbH
CD207 PE Immunotech
CD203 PE Immunotech
CD1a PE BD Biosciences
CD14 PE BD Biosciences
HLA-DR PE BD Biosciences
CD45RA PE BD Biosciences
CD11c PE BD Biosciences
Lactoferrin PE Caltag/An der Grub
CD14 PE ImmunoTools
Jagged-2 PE BioLegend
CD19 PerCP BD Biosciences
NGFP PerCP-Cy5.5 BD Biosciences
CD45 ECD Immunotech
CD117 CyChrome BD Biosciences
CD1a APC BD Biosciences
CD14 APC BD Biosciences
E-Cadherin APC BioLegend
Notch-1 APC BioLegend
E-Cadherin AF647 BD Biosciences
CD11b PE-Cy7 BioLegend
CD11b APC-Cy7 BD Biosciences
CD80 Biotinylated BD Biosciences
CD86 Biotinylated BD Biosciences
CD209 Biotinylated BD Biosciences
CD11b Biotinylated BD Biosciences
CD1a BV412 BD Biosciences
CD1a Pacific Blue BioLegend
The second-step reagent for biotinylated antibodies was streptavidin-PerCP (BD
Biosciences).
APC, Allophycocyanin; ECD, Phycoerythrin-Texas Red; PE, phycoerythrin; PerCP,
peridinin-chlorophyll-protein complex.
J ALLERGY CLIN IMMUNOL
nnn 2016
12.e6 JURKIN ET AL
TABLE E3. Microarray data: mRNAs induced in TGF-b1–stimulated versus nonstimulated cultures
Probe set Gene symbol 0 h
2TGF-b1 1TGF-b1
Sum of calls P value6 h 24 h 6 h 24 h
201131_s_at CDH1 13.3* 14.9 26.1 69.8 470.0 8 <.0001
222549_at CLDN1 8.8 11.2 12.8 34.6 253.8 6 <.0001
220428_at CD207 7.2 6.8 8.2 7.7 197.9 2 <.0001
206337_at CCR7 19.0 16.3 25.4 51.9 77.9 6 .0015
*Microarray expression values generated by using the robust multiarray average algorithm and processed for global normalization.
J ALLERGY CLIN IMMUNOL
VOLUME nnn, NUMBER nn
JURKIN ET AL 12.e7
TABLE E4. Microarray data: mRNAs repressed in TGF-b1–stimulated versus nonstimulated cultures
Probe set Gene symbol 0 h
2TGF-b1 1TGF-b1
Sum of calls P value6 h 24 h 6 h 24 h
209555_s_at CD36 312.3* 389.9 730.6 165.1 343.5 10 .00007
206682_at CLEC10A 217.2 295.3 517.1 214.7 350.1 10 .00310
204438_at MRC1 661.0 775.3 1771.1 372.7 93.6 10 .00001
203305_at FXIIIX 75.7 73.8 73.8 64.4 42.1 7 .00435
*Microarray expression values generated by using the robust multiarray average algorithm and processed for global normalization.
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TABLE E5. Microarray data: KLF family member mRNA regulation in TGF-b1–stimulated versus nonstimulated cultures
Probe set Gene symbol 0 h
2TGF-b1 1TGF-b1
Sum of calls P value6 h 24 h 6 h 24 h
210504_at KLF1 35.9* 34.7 38.9 55.6 41.8 10 .827
219371_s_at KLF2 18.6 16.8 19.2 15.6 17.4 1 .531
222913_at KLF3 65.8 63.0 67.0 63.1 67.2 10 .953
221841_s_at KLF4 111.4 137.6 205.7 52.2 65.0 10 .057
209212_s_at KLF5 31.5 38.4 31.7 26.6 32.9 7 .444
1555832_s_at KLF6 442.8 411.8 605.6 352.4 555.3 10 .010
1555420_a_at KLF7 28.8 32.0 29.9 30.3 29.5 10 .976
219930_at KLF8 5.0 4.6 5.4 4.5 5.2 0 .295
203543_s_at KLF9 4.8 5.0 6.2 4.7 7.5 5 .056
202393_s_at KLF10 116.9 94.9 110.3 221.3 181.6 10 .014
218486_at KLF11 52.0 47.1 55.7 47.2 63.4 10 .211
227261_at KLF12 89.1 77.4 76.8 88.2 104.2 10 .062
225390_s_at KLF13 490.0 458.2 578.2 586.3 635.8 10 .129
1552814_a_at KLF14 9.9 8.9 9.7 8.4 9.4 0 .747
221302_at KLF15 25.7 23.4 27.6 28.2 26.0 0 .668
226328_at KLF16 51.8 50.6 60.8 46.5 58.4 2 .976
1553891_at KLF17 6.7 7.4 7.3 5.9 5.9 0 .628
*Microarray expression values generated by using the robust multiarray average algorithm and processed for global normalization.
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TABLE E6. Ingenuity Pathway Analysis: Notch pathway genes
regulation in TGF-b1–stimulated versus nonstimulated
cultures
Gene symbol
2TGF-b1 1TGF-b1
0 h vs 6 h 0 h vs 24 h 0 h vs 6 h 0 h vs 24 h
HES1 1 1 1.974 1.926
JAG1 1 1.365 21.975 1.857
JAG2 1 1 1.764 1.814
MAML2 1 1 1.419 1.707
PSEN1 1 1.354 1.522 1.573
MAML3 1 1 1 1.319
NOTCH1 1 21.341 1.446 1.316
ADAM17 1 1 1 1.3
CNTN1 1 1.304 1 1
PSEN2* 1 1 21.356 1
MAG 21.305 1 1 1
MFNG 1.342 1 1 1
PSEN2* 1.375 1 1 1
NOTCH2 1 21.367 1 21.545
DTX4 1 1.374 22.293 21.994
*PSEN2 expression was detected by using 2 Affymetrix probe sets: 204261_s_at for
‘‘0 h vs 6 h 2’’ and 211373_s_at for ‘‘0 h vs 6 h 1.’’
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